In hepatocellular carcinoma, the proliferation, migration and invasion of cancer cells were inhibited by miR-497-5p [30]; in non-small cell lung cancer, miR-497-5p suppresses the proliferation and invasion of cancer cells by targeting FGF2 [31]. Here, FGF2 is linked to hepatocellular carcinoma.